Related Experiment Video
Updated: Aug 8, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Replacement of the p16/CDKN2 gene suppresses human glioma cell growth
W Arap1, R Nishikawa, F B Furnari
1Ludwig Institute for Cancer Research, La Jolla, CA 92093-0660.
Abstract:
The p16/CDKN2 gene has many features of a growth suppressor gene: it maps to 9p21, a frequent region of loss of heterozygozity in a variety of tumor types; it encodes an inhibitor of cyclin-dependent kinase 4; and its homozygous deletion is common in tumor-derived cell lines. However, the lower frequency of alteration of the gene in primary tumor tissue as compared to the cognate tumor cell lines has brought this interpretation into question. We have assessed the growth suppressive function of p16/CDKN2 by gene transfer. The introduction of full-length p16/CDKN2 cDNA caused marked growth suppression in p16/CDKN2-null human glioma cells, but was without significant effect in those cells with endogenous wild-type p16/CDKN2 alleles. These results provide functional evidence in support of the hypothesis that the p16/CDKN2 gene is a functional growth suppressor gene, at least in gliomas.
Insights
The p16/CDKN2 gene, a cell growth inhibitor, functions as a tumor suppressor. Introducing this gene into glioma cells lacking it halted their growth, confirming its suppressive role.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p16/CDKN2 gene is a candidate tumor suppressor due to its mapping to a frequently altered chromosomal region (9p21) and its role as a cyclin-dependent kinase inhibitor.
- Observed discrepancies in p16/CDKN2 alteration frequencies between tumor cell lines and primary tumors prompted further investigation into its functional role.
Purpose of the Study:
- To functionally validate the growth-suppressive capacity of the p16/CDKN2 gene.
- To investigate the role of p16/CDKN2 in glioma cell proliferation.
Main Methods:
- Gene transfer of full-length p16/CDKN2 cDNA into human glioma cells.
- Comparison of growth suppression effects in p16/CDKN2-null cells versus cells with endogenous wild-type p16/CDKN2.
Main Results:
- Introduction of p16/CDKN2 cDNA significantly suppressed the growth of p16/CDKN2-null glioma cells.
- Glioma cells already possessing wild-type p16/CDKN2 alleles showed no significant growth inhibition upon gene transfer.
Conclusions:
- These findings provide functional evidence that the p16/CDKN2 gene acts as a growth suppressor, particularly in the context of gliomas.
- The study supports the hypothesis of p16/CDKN2 as a functional tumor suppressor gene in specific cancer types.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
09:36Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...